These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20193638)

  • 1. Glioblastoma genetics: in rapid flux.
    Purow BW; Schiff D
    Discov Med; 2010 Feb; 9(45):125-31. PubMed ID: 20193638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.
    Floyd D; Purow B
    Neuro Oncol; 2014 May; 16(5):622-7. PubMed ID: 24723563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme.
    Mazurek M; Litak J; Kamieniak P; Osuchowska I; Maciejewski R; Roliński J; Grajkowska W; Grochowski C
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of glioma.
    Marumoto T; Saya H
    Adv Exp Med Biol; 2012; 746():2-11. PubMed ID: 22639155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?
    Purow B
    J Neurooncol; 2011 Jul; 103(3):429-36. PubMed ID: 21082214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies.
    Costa PM; Cardoso AL; Mano M; de Lima MC
    CNS Neurol Disord Drug Targets; 2015; 14(2):222-38. PubMed ID: 25613511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair mechanisms and their clinical impact in glioblastoma.
    Erasimus H; Gobin M; Niclou S; Van Dyck E
    Mutat Res Rev Mutat Res; 2016; 769():19-35. PubMed ID: 27543314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in epigenetic glioblastoma therapy.
    Lee DH; Ryu HW; Won HR; Kwon SH
    Oncotarget; 2017 Mar; 8(11):18577-18589. PubMed ID: 28099914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.
    Szopa W; Burley TA; Kramer-Marek G; Kaspera W
    Biomed Res Int; 2017; 2017():8013575. PubMed ID: 28316990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma cancer stem cells: Biomarker and therapeutic advances.
    Pointer KB; Clark PA; Zorniak M; Alrfaei BM; Kuo JS
    Neurochem Int; 2014 May; 71():1-7. PubMed ID: 24657832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.
    Van Meir EG; Hadjipanayis CG; Norden AD; Shu HK; Wen PY; Olson JJ
    CA Cancer J Clin; 2010; 60(3):166-93. PubMed ID: 20445000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
    Parvez T
    Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of glioblastoma: State of the art and future directions.
    Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
    CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges.
    Nicholas MK; Lukas RV; Chmura S; Yamini B; Lesniak M; Pytel P
    Semin Oncol; 2011 Apr; 38(2):243-53. PubMed ID: 21421114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs involved in the EGFR pathway in glioblastoma.
    Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
    Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic landscape of glioblastoma and the potential clinical utility.
    Wang CJ; Choe KS
    CNS Oncol; 2014 May; 3(3):169-72. PubMed ID: 25055121
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral therapy for glioblastoma.
    Chiocca EA; Aghi M; Fulci G
    Cancer J; 2003; 9(3):167-79. PubMed ID: 12952302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.